Literature DB >> 10207238

Specific prognostic factors for secondary pancreatic infection in severe acute pancreatitis.

M Armengol-Carrasco1, B Oller, L E Escudero, J Roca, J Gener, N Rodríguez, P del Moral, P Moreno.   

Abstract

BACKGROUND/AIMS: The aim of the present study was to investigate whether there are specific prognostic factors to predict the development of secondary pancreatic infection (SPI) in severe acute pancreatitis in order to perform a computed tomography-fine needle aspiration with bacteriological sampling at the right moment and confirm the diagnosis.
METHODS: Twenty-five clinical and laboratory parameters were determined sequentially in 150 patients with severe acute pancreatitis (SAP) and univariate, and multivariate regression analyses were done looking for correlation with the development of SPI.
RESULTS: Only APACHE II score and C-reactive protein levels were related to the development of SPI in the multivariate analysis. A regression equation was designed using these two parameters, and empiric cut-off points defined the subgroup of patients at high risk of developing secondary pancreatic infection.
CONCLUSION: The results showed that it is possible to predict SPI during SAP allowing bacteriological confirmation and early treatment of this severe condition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207238     DOI: 10.1159/000018704

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  2 in total

1.  Infectious complications in patients with severe acute pancreatitis.

Authors:  Ping Xue; Li-Hui Deng; Zhao-Da Zhang; Xiao-Nan Yang; Mei-Hua Wan; Bing Song; Qing Xia
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

2.  Identification of early predictors for infected necrosis in acute pancreatitis.

Authors:  Mats L Wiese; Steffi Urban; Sabrina von Rheinbaben; Fabian Frost; Matthias Sendler; Frank Ulrich Weiss; Robin Bülow; Marie-Luise Kromrey; Quang Trung Tran; Markus M Lerch; Birgit Schauer; Ali A Aghdassi
Journal:  BMC Gastroenterol       Date:  2022-09-03       Impact factor: 2.847

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.